Arkolith/Insider Trading/IDYA/Form 4

Hata Yujiro S

President and CEO, DirectorIDEAYA Biosciences, Inc. (IDYA) · full profile →Form 4 · filed Dec 19, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2.6M
Net Open-Market Flow
-$2.6M
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 15, 2023Option exercise(M)75K$4.31$323K753K
Dec 15, 2023Sell(S)75K$35.03$2.6M678K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 15, 2023Option exercise(M)75K—$0399K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001610717-23-000405) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML